Added to YB: 2026-05-04
Pitch date: 2026-04-30
PRTC [bullish]
PureTech Health plc
+4.68%
current return
Author Info
The Oak Bloke shares analysis of the UK stock market, particularly overlooked small caps. Sign up for the newsletter.
Company Info
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
Market Cap
GBP 427.4M
Pitch Price
GBP 1.33
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.05
P/E
8.71
EV/Sales
39.55
Sector
Biotechnology
Category
value
PRTC-tock and the Seaport clock
PRTC: $405M mcap - $277M cash = $127.7M for 100% Celea (Phase 3 IPF w/ 81% treatment effect vs 54% existing drug, $10B TAM), 100% Gallop (Phase 1 oncology), 26.3% SPTX (IPO'd at $912M valuation = $240M stake), 2% Cobenfy royalty >$2B sales + $400M milestones. 2025 loss -$0.46/sh incl -$0.29/sh non-cash royalty provision; actual cash burn declining post spinouts vs broker -$0.69/sh 2027 loss est despite $77M Cobenfy income guidance.
Read full article (6 min)